Question 1 · Hard
A 49-year-old woman with type 2 diabetes started empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, 2 months ago and now has vulval itching. Her fresh urine: SG 1.025, pH 5.5, glucose 4+, blood negative, ascorbic acid negative, nitrite and leukocyte esterase negative; strip QC is acceptable. A trainee has reported '10-20 RBC/HPF'. On review, the colorless oval bodies vary in size, some carry small buds, a few form short branching chains, they are not birefringent under polarized light, and they stay intact after 2% acetic acid is added. The sediment should be reported as:
- ABudding yeast, not red cells
- BCalcium oxalate monohydrate ovals
- CRed cells missed by the blood pad
- DOil droplets from a lubricant
Show answerHide answer
Answer: A · Budding yeast, not red cells
Yeast cells are oval, vary in size and show budding and sometimes pseudohyphae, which separates them from red cells. Red cells lyse in 2% acetic acid while yeast stays intact, and the negative blood pad, with a negative ascorbic acid pad and acceptable QC, agrees that no red cells are present. Calcium oxalate monohydrate ovals are birefringent, and oil droplets are highly refractile spheres that never bud. SGLT2 inhibitors cause heavy glycosuria, which favors Candida growth in the genital and urinary tract. Report the yeast and correct the red cell count.
- B: Calcium oxalate monohydrate is birefringent and does not bud.
- C: The blood pad is negative with acceptable QC and no ascorbic acid, and red cells would lyse in acetic acid.
- D: Oil droplets are refractile spheres that do not bud or form chains.